HSA Grants Interim Authorisation for Paxlovid™, the First Oral Medicine for Treatment of COVID-19 Infection
Melissa Fann
The Health Sciences Authority (HSA), in consultation with its Medicines Advisory Committee, has on 31 January 2022, granted interim authorisation under the Pandemic Special Access Route (PSAR) for Pfizer’s PAXLOVID™,…
